A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

Also called NCT05759897

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose other
Phase
Phase 2
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05759897
Other papers using this trial's data
  • HRS-7535 for Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized Clinical Trial JAMA network open, 2026-06-01 DOI, PubMed 42234428, PMC13234685 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05759897. Randomized; double masking; primary purpose other. Start 2023-02-28 (anticipated); primary completion 2023-12-21 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus
Intervention (Drug)
HRS-7535
Intervention (Drug)
Placebo
Lead sponsor
Shandong Suncadia Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05759897
Content hash
d0a1388ba1ddf3784ed8649003a2d389ac6e48a025a785d6c3468435688a9f46